English | Español

Texas House of Representatives
Patient Daily | Dec 31, 2025

Texas House Majority leader Oliverson: 340B is a 'dumpster fire of a program'

Trending
+ Pharmaceuticals
Patient Daily | Jan 12, 2026

Six major FDA drug decisions expected in early 2026
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

PhRMA warns of cancer drug markups, 340B program profiteering
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Big pharma leads Q4 biopharma M&A as smaller biotech deals gain momentum
+ Pharmaceuticals
Patient Daily | Jan 7, 2026

Pfizer leads U.S. drugmakers in planned price increases for 2026